Literature DB >> 16810835

Survival after Transfusion of Rh-positive Erythrocytes Previously Incubated with Rh Antibody.

P L Mollison1.   

Abstract

Year:  1949        PMID: 16810835      PMCID: PMC1023242     

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


× No keyword cloud information.
  1 in total

1.  Haemolytic disease of the newborn; criteria of severity.

Authors:  P L MOLLISON; M CUTBUSH
Journal:  Br Med J       Date:  1949-01-22
  1 in total
  7 in total

1.  Anemia in rheumatoid arthritis. I. Red cell survival studies.

Authors:  A BIECHL; J E STAPLETON; J F WOODBURY; H C READ
Journal:  Can Med Assoc J       Date:  1962-03-03       Impact factor: 8.262

2.  The destruction of red cells by antibodies in man. I. Observations of the sequestration and lysis of red cells altered by immune mechanisms.

Authors:  J H JANDL; A R JONES; W B CASTLE
Journal:  J Clin Invest       Date:  1957-10       Impact factor: 14.808

3.  Radioactive iron metabolism and erythrocyte survival studies of the mechanism of the anemia associated with rheumatoid arthritis.

Authors:  E J FREIREICH; J F ROSS; T B BAYLES; C P EMERSON; S C FINCH
Journal:  J Clin Invest       Date:  1957-07       Impact factor: 14.808

4.  Marrow iron examination in the diagnosis of iron deficiency in rheumatoid arthritis.

Authors:  P C McCREA
Journal:  Ann Rheum Dis       Date:  1958-03       Impact factor: 19.103

5.  Discussion on anaemia in rheumatoid arthritis.

Authors:  J J DUTHIE; A S DIXON; M R JEFFREY
Journal:  Proc R Soc Med       Date:  1956-01

6.  Erythrocyte survival in normal mice and in mice with autoimmune haemolytic anaemia.

Authors:  E S Lindsey; G W Donaldson; M F Woodruff
Journal:  Clin Exp Immunol       Date:  1966-01       Impact factor: 4.330

7.  Nature of anaemia in rheumatoid arthritis. II. Survival of transfused erythrocytes in patients with rheumatoid arthritis.

Authors:  W R ALEXANDER; J RICHMOND; L M ROY; J J DUTHIE
Journal:  Ann Rheum Dis       Date:  1956-03       Impact factor: 19.103

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.